Physician profile
Harold E Giles
NPI 1811945454
$17,720.56
in general payments reported to CMS, 2019-2025
12 companies · $25.63 in 2025
The $25.63 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $3,018 · 2021: $5,241 · 2022: $8,369 · 2023: $159 · 2024: $70.82 · 2025: $25.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $9,849.33 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $7,252.45 | 2021-2024 | Nxstage System One, Liberty Select Cycler |
| Akebia Therapeutics INC | $285.73 | 2019-2025 | Auryxia, Vafseo |
| Amgen INC. | $116.01 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $86.93 | 2023 | Farxiga |
| Horizon Therapeutics Plc | $26.00 | 2023 | |
| Travere Therapeutics, INC. | $21.79 | 2023 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Glaxosmithkline, LLC. | $18.16 | 2022 | |
| Genzyme Corporation | $18.12 | 2021 | |
| Baxter Healthcare | $14.08 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Giles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.